Observia
Chia-Chun Chen serves as the Key Account Director for Germany at Observia, an innovative eHealth company focused on leveraging behavioral sciences to enhance patient support and healthcare professional collaboration. Previous experience includes working as an Innovation Business Consultant in Life Sciences at Alcimed, where Chia-Chun contributed to driving innovation across various specialized sectors. Additionally, tenure as a Project Manager and Senior Research Fellow at the Free University of Berlin involved significant contributions to research on European economic policy-making. Chia-Chun also acted as Regional Coordinator for the Institute for New Economic Thinking in Berlin, fostering new economic thinkers and theories. Educational qualifications include a Ph.D. in International Political Economy and a Master’s Degree in International Relations from reputable institutions in Germany, along with an exchange program in Japan and a Bachelor’s Degree in Japanese Language and Literature from National Taiwan University.
This person is not in any offices
Observia
Since 2011, we have been a passionate pioneering health tech company committed to driving the healthcare (r)evolution and improving patients’ lives. We work with healthcare stakeholders that aim to create value at every step of the patient journey: industrial companies, healthcare facilities, healthcare professionals, and patient organizations. As a European reference, we help companies to develop personalized, intelligent patient engagement and support solutions, and to define and implement patient strategies. We have created a new generation of evidence-based tools to support efficient patient behavioral change and improve the user experience. d.tells™, our smart engine for personalizing patient solutions, is powered by SPUR™, our behavioral diagnostic tool, and OPC™, our digital cloud platform that supports client’s developments. Our products are anchored in the behavioral sciences and driven by artificial intelligence, two critical pillars that promote effective personalization. These tools successfully help patients to overcome behavioral challenges, such as treatment non-adherence, and deliver clinically measurable results. Observia has been created in 2011 by three founders. After 3 years in Paris Biotech Santé incubator in Cochin hospital, Observia settled in Paris and opened a subsidiary in Shanghai in 2018. In 2021, the company employs more than 50 people and does 60% of its turnover internationally.